Florence, the company that advances clinical trials with software, welcomes healthcare IT industry veteran Steve Chamberlain to its advisory network. Chamberlain, who also made an undisclosed investment in Florence, brings experience driving growth at disruptive...
In Collaboration with Colorado State University College of Veterinary Medicine and Biomedical Sciences, and Downing Center for Pain Management HempMy Pet™, a vertically integrated Colorado Hemp company that grows medicinal hemp and produces CBD-infused pet products,...
Topline data from ORCA-1 trial expected in the Second Quarter of 2019 Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced...
Amylyx Pharmaceuticals, Inc., in collaboration with the Alzheimer’s Association, the Alzheimer’s Drug Discovery Foundation (ADDF) and the Cure Alzheimer’s Fund, today announced the dosing of its first patients in a recently expanded Phase 2 clinical trial (PEGASUS) to...
Next Generation Antibody-Drug Conjugate Developed Using Catalent’s SMARTag® ADC Technology Triphase Accelerator Corporation, a company dedicated to acquiring and developing novel therapeutics for the treatment of cancer, and Catalent, the leading global provider of...
– First patient dosed in new cohort of Phase II trial evaluating selective AXL inhibitor bemcentinib in combination with KEYTRUDA in patients with advanced NSCLC whose disease is progressing on anti-PD(L)1 therapy – New cohort added under existing...
Email
Text